David Lam, OD
Optometry · Gilroy
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · County of Santa Clara · 1,000 clinicians in this group
Looking this up.
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Lam’s office at (408) 885-5000 to ask if they take your plan before you enroll.
California Medical Board record
Licence G14960 · Cancelled
Licence status: Cancelled · since 1968 · New York Medical College.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$5,407
Medicare paid this office $5,407 for 265 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Photography of the retina | 184 | $3,127 | $17 |
| Photography of the retina | 69 | $1,704 | $23 |
| Exam of the internal drainage system of eye | 16 | $219 | $14 |
Who their Medicare patients are
265 Original Medicare patients in 2024. Average age 71 · Under 65 14% · 85 and older 8% · Women 59% · Also on Medicaid 78% · Health risk score 1.45. Sicker patients than 9 in 10 peers; the typical optometry clinician is at 0.97.
Conditions among them: High blood pressure 75% · Diabetes 75% · Chronic kidney disease 28% · Coronary heart disease 21% · Heart failure 18% · Depression 13% · Atrial fibrillation 11% · COPD 10% · Cancer 8% · Stroke 6% · Dementia 5%.
The office billed $137,469, Medicare allowed $8,966 and paid $5,407; for 288 services of 9 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 265 | 288 | 71 | 1.45 | $137,469 | $5,407 |
| 2023 | 56 | 97 | 70 | 1.40 | $70,200 | $2,055 |
| 2022 | 70 | 92 | 69 | 1.29 | $59,626 | $1,482 |
| 2021 | 222 | 269 | 69 | 1.32 | $101,724 | $4,523 |
| 2020 | 219 | 266 | 69 | 1.28 | $103,287 | $4,394 |
| 2019 | 437 | 522 | 70 | 1.33 | $277,702 | $14,373 |
| 2018 | 528 | 616 | 68 | 1.35 | $332,816 | $11,264 |
| 2017 | 325 | 378 | 68 | 1.34 | $205,188 | $8,039 |
| 2016 | 297 | 361 | 69 | 1.42 | $108,064 | $7,489 |
| 2015 | 437 | 501 | 69 | 1.37 | $102,334 | $9,613 |
| 2014 | 19 | 19 | 71 | 1.11 | $6,432 | $848 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Photography of the retina | 36 | $1,074 | $26 |
| Exam of the internal drainage system of eye | 18 | $224 | $12 |
| Exam of visual field with extended testing | 13 | $206 | $16 |
| Imaging of optic nerve | 14 | $164 | $12 |
2022: 2 services
| Photography of the retina | 44 | $1,017 | $22 |
| Photography of the retina | 14 | $20 | $1 |
2021: 5 services
| Photography of the retina | 165 | $2,249 | $14 |
| Photography of the retina | 43 | $1,261 | $26 |
| Exam of visual field with extended testing | 18 | $313 | $17 |
| Exam of the internal drainage system of eye | 11 | $199 | $18 |
| Imaging of retina | 14 | $196 | $14 |
2020: 5 services
| Photography of the retina | 153 | $2,096 | $14 |
| Photography of the retina | 40 | $844 | $20 |
| Exam of the internal drainage system of eye | 28 | $530 | $19 |
| Exam of visual field with extended testing | 13 | $216 | $17 |
| Imaging of optic nerve | 12 | $152 | $13 |
2019: 6 services
| Photography of the retina | 304 | $3,897 | $13 |
| Established patient complete exam of visual system | 59 | $3,880 | $66 |
| Established patient complete exam of visual system | 17 | $1,586 | $93 |
| Photography of the retina | 33 | $1,333 | $35 |
| Exam of visual field with extended testing | 29 | $666 | $22 |
| Imaging of optic nerve | 26 | $475 | $18 |
2018: 6 services
| Photography of the retina | 431 | $5,261 | $12 |
| Established patient complete exam of visual system | 38 | $2,016 | $52 |
| Photography of the retina | 41 | $1,763 | $39 |
| Established patient problem focused exam of visual system | 14 | $758 | $40 |
| Exam of visual field with extended testing | 22 | $540 | $20 |
| Imaging of optic nerve | 22 | $389 | $16 |
2017: 6 services
| Photography of the retina | 242 | $2,659 | $11 |
| Established patient complete exam of visual system | 25 | $1,702 | $68 |
| Photography of the retina | 28 | $1,373 | $46 |
| Return visit (30+ min) | 23 | $1,173 | $51 |
| Exam of visual field with extended testing | 17 | $253 | $15 |
| Imaging of optic nerve | 15 | $224 | $15 |
2016: 6 services
| Photography of the retina | 223 | $3,067 | $14 |
| Return visit (30+ min) | 48 | $2,796 | $58 |
| Short return visit (20+ min) | 15 | $582 | $29 |
| Exam of visual field with extended testing | 17 | $338 | $19 |
| Imaging of optic nerve | 11 | $234 | $21 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 17 | $91 | $5 |
2015: 3 services
| Photography of the retina | 384 | $6,447 | $15 |
| Return visit (30+ min) | 33 | $1,817 | $55 |
| Short return visit (20+ min) | 21 | $812 | $37 |
Medicaid work
$480,752 in 2024
Medicaid paid $480,752 for 6,080 billed services this clinician did in 2024, up to 103 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 807 | $413,932 |
| Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 130 | $58,172 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 691 | $5,581 |
| FUNDUS PHOTOGRAPHY W/INTERPRETATION & REPORT | 483 | $2,867 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 358 | $82 |
| DETERMINATION REFRACTIVE STATE | 491 | $69 |
| Return visit (30+ min) | 123 | $49 |
| Pain severity quantified; no pain present (COA) (ONC) | 572 | $0 |
| Medication list documented in medical record (COA) | 719 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 548 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 188 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 76 | $0 |
| 2024 | 6,080 | 16 | 103 | $480,752 |
| 2023 | 5,602 | 13 | 132 | $409,034 |
| 2022 | 2,989 | 10 | 86 | $217,213 |
| 2021 | 3,101 | 11 | 84 | $323,640 |
| 2020 | 2,589 | 6 | 90 | $232,960 |
| 2019 | 2,169 | 7 | 117 | $191,260 |
| 2018 | 2,808 | 7 | 130 | $206,000 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 782 | $386,275 |
| Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 28 | $12,380 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 1,241 | $7,300 |
| FUNDUS PHOTOGRAPHY W/INTERPRETATION & REPORT | 1,296 | $2,796 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 447 | $74 |
| GONIOSCOPY | 17 | $73 |
| DETERMINATION REFRACTIVE STATE | 664 | $72 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 39 | $63 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 129 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 320 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 93 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 70 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 431 | $208,262 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 745 | $7,114 |
| FUNDUS PHOTOGRAPHY W/INTERPRETATION & REPORT | 640 | $1,751 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 232 | $68 |
| DETERMINATION REFRACTIVE STATE | 250 | $18 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 83 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 232 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 44 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 25 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 307 | $0 |
2021
| Clinic visit/encounter, all-inclusive | 686 | $321,484 |
| FUNDUS PHOTOGRAPHY W/INTERPRETATION & REPORT | 458 | $1,619 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 618 | $521 |
| DETERMINATION REFRACTIVE STATE | 340 | $16 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 73 | $0 |
| HEMOGLOBIN A1C LEVEL >9.0% | 13 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 272 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 32 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 13 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 359 | $0 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 237 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 700 | $219,833 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 849 | $12,711 |
| FUNDUS PHOTOGRAPHY W/INTERPRETATION & REPORT | 327 | $389 |
| Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only | 16 | $27 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 331 | $0 |
| DETERMINATION REFRACTIVE STATE | 366 | $0 |
2019
| Clinic visit/encounter, all-inclusive | 565 | $174,173 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 523 | $12,804 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 53 | $3,377 |
| FUNDUS PHOTOGRAPHY W/INTERPRETATION & REPORT | 504 | $889 |
| DETERMINATION REFRACTIVE STATE | 294 | $16 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 187 | $0 |
| Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 43 | $0 |
2018
| Clinic visit/encounter, all-inclusive | 645 | $196,086 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 359 | $4,788 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 91 | $3,686 |
| FUNDUS PHOTOGRAPHY W/INTERPRETATION & REPORT | 1,129 | $1,082 |
| Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 120 | $200 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 181 | $157 |
| DETERMINATION REFRACTIVE STATE | 283 | $0 |
Drugs they prescribed that Part D paid
$15,362
Pharmacies billed $15,362 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 278) in 2024. At or below the middle of the specialty; the typical optometry clinician is at 0%.
228 generic and 50 brand-name prescriptions · $15,362 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Latanoprost | 133 | $2,203 | $17 |
| Travoprost | 11 | $1,001 | $91 |
| Timolol Maleate | 34 | $333 | $10 |
| Brimonidine | 16 | $268 | $17 |
| Dorzolamide-Timolol | 14 | $195 | $14 |
See all 6 drugs
| Latanoprost | 133 | $2,203 | $17 |
| Travoprost | 11 | $1,001 | $91 |
| Timolol Maleate | 34 | $333 | $10 |
| Brimonidine | 16 | $268 | $17 |
| Dorzolamide-Timolol | 14 | $195 | $14 |
| Ketorolac Tromethamine | 14 | $144 | $10 |
Year by year
| 2024 | 278 | 65 | 0% (0) | 18% | $15,362 |
| 2023 | 253 | 61 | 0% (0) | 17% | $13,593 |
| 2022 | 217 | 62 | 0% (0) | 22% | $18,799 |
| 2021 | 233 | 61 | 0% (0) | 28% | $25,093 |
| 2020 | 240 | 62 | 0% (0) | 34% | $26,315 |
| 2019 | 234 | 57 | 0% (0) | 33% | $30,476 |
| 2018 | 249 | 61 | 0% (0) | 37% | $27,701 |
| 2017 | 233 | 52 | 0% (0) | 30% | $20,651 |
| 2016 | 186 | 39 | 0% (0) | 23% | $10,665 |
| 2015 | 50 | 21 | 0% (0) | 32% | $3,278 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
| Latanoprost | 118 | $2,955 | $25 |
| Brimonidine | 11 | $2,429 | $221 |
| Ketorolac Tromethamine | 24 | $580 | $24 |
| Olopatadine | 19 | $361 | $19 |
| Timolol Maleate | 26 | $319 | $12 |
| Dorzolamide-Timolol | 15 | $305 | $20 |
2022: 5 drugs
| Restasis | 11 | $5,240 | $476 |
| Latanoprost | 100 | $2,376 | $24 |
| Timolol Maleate | 19 | $327 | $17 |
| Dorzolamide-Timolol | 14 | $256 | $18 |
| Ketorolac Tromethamine | 11 | $193 | $18 |
2021: 4 drugs
| Restasis | 34 | $14,397 | $423 |
| Latanoprost | 107 | $2,684 | $25 |
| Timolol Maleate | 34 | $560 | $16 |
| Dorzolamide-Timolol | 11 | $223 | $20 |
2020: 5 drugs
| Restasis | 39 | $14,956 | $383 |
| Travatan Z | 15 | $3,791 | $253 |
| Latanoprost | 96 | $2,697 | $28 |
| Dorzolamide-Timolol | 11 | $486 | $44 |
| Timolol Maleate | 28 | $331 | $12 |
2019: 5 drugs
| Restasis | 35 | $14,885 | $425 |
| Travatan Z | 21 | $9,847 | $469 |
| Latanoprost | 91 | $2,186 | $24 |
| Dorzolamide-Timolol | 13 | $444 | $34 |
| Timolol Maleate | 27 | $204 | $8 |
2018: 6 drugs
| Restasis | 35 | $12,868 | $368 |
| Travatan Z | 14 | $5,926 | $423 |
| Fluorometholone | 16 | $1,848 | $116 |
| Latanoprost | 72 | $1,501 | $21 |
| Dorzolamide-Timolol | 21 | $372 | $18 |
| Timolol Maleate | 28 | $265 | $9 |
2017: 4 drugs
| Restasis | 30 | $11,141 | $371 |
| Latanoprost | 94 | $1,500 | $16 |
| Dorzolamide-Timolol | 15 | $255 | $17 |
| Timolol Maleate | 24 | $220 | $9 |
2016: 4 drugs
| Restasis | 17 | $4,301 | $253 |
| Latanoprost | 86 | $1,261 | $15 |
| Timolol Maleate | 21 | $265 | $13 |
| Dorzolamide-Timolol | 15 | $250 | $17 |
2015: 1 drug
| Latanoprost | 20 | $314 | $16 |
Money from drug and device companies
$89 in 2022
| 2022 | 1 | 1 | None | $89 |
| 2019 | 1 | 1 | None | $125 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Optos | Oct Ophthalmoscope | $89 | 1 payment
|
See the published payment
| Optos | Meals · 2022-06-05 | Oct Ophthalmoscope | $89 |
See earlier years (2019)
2019: $125
| Shire North American Group | Xiidra | $125 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1942613575
- Licence
- CA 14960California G14960: Cancelled
- Trained
- State University of New York - State College Optometry, 2014
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 152W00000X (152W00000X)
- Mailing address
- 7475 Camino Arroyo, Gilroy, CA, 95020
- NPI first listed
- 2014-06-11
- NPI last updated
- 2015-06-19
This is when the NPI record was last certified, not a medical board exam.